Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015-Reference-Cited by-同舟云学术

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

Published:2008-05 Issue:5 Volume:19 Page:920-926
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Köhne C.-H.,De Greve J.,Hartmann J.T.,Lang I.,Vergauwe P.,Becker K.,Braumann D.,Joosens E.,Müller L.,Janssens J.,Bokemeyer C.,Reimer P.,Link H.,Späth-Schwalbe E.,Wilke H.-J.,Bleiberg H.,Van Den Brande J.,Debois M.,Bethe U.,Van Cutsem E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/5/920/398859/mdm544.pdf

Reference30 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Estimates of the cancer incidence and mortality in Europe in 2006;Ferlay;Ann Oncol,2007

3. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates;Folprecht;Ann Oncol,2005

4. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis;Thirion;J Clin Oncol,2004

5. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer;Meta-analysis Group In Cancer;J Clin Oncol,1998

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wnt/β-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells;Biomedicine & Pharmacotherapy;2024-06

2. Cardiovascular/anti‐inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta‐analysis of randomized trials;Cancer Medicine;2024-03

3. The effective combination therapies with irinotecan for colorectal cancer;Frontiers in Pharmacology;2024-02-05

4. Selective COX-2 inhibitors do not increase gastrointestinal reactions after colorectal cancer surgery: a systematic review and meta-analysis;BMC Gastroenterology;2023-08-14

5. Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer;Frontiers in Oncology;2023-04-06